PTC Therapeutics to Host Conference Call to Discuss Second Quarter 2024 Financial Results
PTC Therapeutics (NASDAQ: PTCT) has announced a webcast conference call to discuss its second quarter 2024 financial results and provide a business update.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
PTC Therapeutics (NASDAQ: PTCT) has announced a webcast conference call to discuss its second quarter 2024 financial results and provide a business update. The call is scheduled for Thursday, August 8, at 4:30 p.m. EDT. Participants can access the call by phone after registering for dial-in details. To avoid delays, it's recommended to dial in 15 minutes before the call starts. The webcast can be accessed on the Investor section of PTC's website. A replay will be available approximately two hours after the call ends and will be archived on the company's website for 30 days.
Details
News Market Reaction – PTCT
The recorded move for PTCT in the trading session of this news was +1.55%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
To access the call by phone, please click here to register and you will be provided with dial-in details. To avoid delays, we recommend participants dial in to the conference call 15 minutes prior to the start of the call. The webcast conference call can be accessed on the Investor section of the PTC website at https://ir.ptcbio.com/events-presentations. A replay of the call will be available approximately two hours after completion of the call and will be archived on the company's website for 30 days.
About PTC Therapeutics, Inc.
PTC is a global biopharmaceutical company focused on the discovery, development and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. PTC's ability to innovate to identify new therapies and to globally commercialize products is the foundation that drives investment in a robust and diversified pipeline of transformative medicines. PTC's mission is to provide access to best-in-class treatments for patients who have little to no treatment options. PTC's strategy is to leverage its strong scientific and clinical expertise and global commercial infrastructure to bring therapies to patients. PTC believes this allows it to maximize value for all its stakeholders. To learn more about PTC, please visit us at www.ptcbio.com and follow us on Facebook, Instagram, LinkedIn and Twitter at @PTCBio.
For More Information:
Investors:
Kylie O'Keefe
+1 (908) 300-0691
kokeefe@ptcbio.com
Media:
Jeanine Clemente
+1 (908) 912-9406
jclemente@ptcbio.com
View original content:https://www.prnewswire.com/news-releases/ptc-therapeutics-to-host-conference-call-to-discuss-second-quarter-2024-financial-results-302207070.html
SOURCE PTC Therapeutics, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.